News

Filter

Current filters:

KepivanceAmgen

Biovitrum and Amgen close product deal

22-12-2008

Sweden's Biovitrum says it has closed an agreement signed with US biotechnology giant Amgen (Marketletter…

AmgenAnakinraKepivanceKineretPalifermin

Biovitrum pays Amgen initial $130M for drugs

22-09-2008

Sweden's Biovitrum has acquired rights to three marketed products from US biotechnology giant Amgen.…

AmgenAnakinraKepivanceKineretPalifermin

Amgen's Kepivance gets nod from CHMP

08-08-2005

US biotechnology major Amgen has received a positive marketing authorization opinion from the European…

AmgenKepivanceNystatinOralPalifermin

FDA clears Amgen's Kepivance

20-12-2004

The US Food and Drug Administration has approved the use of Amgen's Kepivance (palifermin) for the treatment…

AmgenAntihemophilic FactorCoagulation Factor VIIaKepivanceNystatinOralPaliferminRecombinant

Amgen files palifermin BLA with FDA

05-07-2004

US biotechnology giant Amgen has submitted a Biologics LicenseApplication to the US Food and Drug Administration…

AmgenAntihemophilic FactorCoagulation Factor VIIaKepivanceNystatinOralPaliferminRecombinant

Back to top